HOME >> MEDICINE >> NEWS
Patients should be allowed to pay for statins

GPs should be able to offer private prescriptions for cholesterol lowering drugs (statins) to patients below 3% risk of heart disease, argue researchers in this week's BMJ.

Statins can help prevent coronary heart disease in people whose annual risk is 0.6% or more. Yet this would lead to treatment of over 40% of the British adult population, and would be unaffordable under the NHS.

Current medical practice therefore recommends treatment only for those with a risk of over 3% a year, but this denies effective treatment to 32% of the adult population.

However, if patients who are currently ineligible for statins were told that they could benefit from these drugs, some might be willing to pay for a private prescription, suggest GP, Nick Raithatha and health economist, Richard Smith.

They predict that the cost of private treatment with monitoring by an NHS practice nurse would eventually be 93.66 a year. This is far less than average household expenditure on, for example, alcohol (320), clothes (380) and motoring (920), and may therefore be quite affordable to people on average earnings.

Although private prescriptions would increase inequality in access to health care, this is a form of inequality whereby all members of society gain and is therefore both economically and ethically jusifiable, they conclude.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-20-7383-6529
BMJ-British Medical Journal
12-Feb-2004


Page: 1

Related medicine news :

1. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
2. Patients with cancer have highly increased risk for blood clots
3. Patients with previous heart attacks may not benefit from pacemaker implant
4. Patients with cancer detected on screening mammography undergo less toxic treatment
5. Patients with moderate or severe hand dermatitis responsive to drug therapy
6. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
7. Patients who are intubated prior to hospital arrival fare worse find Pitt researchers
8. Patients undergoing weight loss surgery have high rates of H pylori bacteria
9. Patients with chronic sinus do not necessarily develop antibiotic resistance
10. Plastic surgeons honor Patients of Courage overcoming difficult obstacles, inspiring others
11. Patients with severe depression improve using guidelines developed by UT Southwestern researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Patients should allowed pay for statins

(Date:8/5/2015)... ... , ... The June 6 opening of Chicago’s new elevated trail, the 606, has been getting ... a group of walkers at Sedgebrook senior living community in Lincolnshire. Known as the ... preserves and twice per month to more distant places. When they read about the ...
(Date:8/5/2015)... ... 05, 2015 , ... What language does a body speak? "Body Language ... idioms and other expressions that contain the name of a body part. , The ... about 2,000 such idioms, words, and expressions, for example, “back against the wall,” “brainstorming,” ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... filed in the testosterone multidistrict litigation known as Testosterone Replacement Therapy Products Liability ... Northern District of Illinois. The Motion to Dismiss was filed by the defendants, ...
(Date:8/5/2015)... ... ... Wildflower Seed & Tool Company ” was featured on NewsWatch as part of its ... impact in their industry. Susan Bridges, a reporter for NewsWatch and a business expert, ... designed for women. , With overweight gardening tools that seem like they’re designed for ...
(Date:8/5/2015)... ... ... Available in select spas and at http://www.lespausa.com , Phytomer ... oils. A perfect complement to Phytomer’s top selling product, ROSÉE VISAGE Cleansing Toning ... soothing properties. Formulated as a light and comfortable dry oil, it quickly penetrates the ...
Breaking Medicine News(10 mins):Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4
(Date:8/4/2015)... SEATTLE , Aug. 4, 2015  Dr. ... Institute states the potential FDA approval of flibanserin, ... sets women and the treatment of decreased female ... women has many root causes and addressing libido ... is dangerous. ...
(Date:8/4/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported net ... three and six months ended June 30, 2015, respectively, ... $43.4 million for the same periods in 2014. Isis, ... more than $90 million of revenue Isis earned in ... Bayer to license  ISIS-FXI Rx .  Isis increased its ...
(Date:8/4/2015)... 2015  Intec Pharma Ltd. (the "Company") (NASDAQ: ... developing drugs based on its proprietary Accordion Pill platform ... offering in the United States ... to the public of $6.00 per ordinary share, before ... are being offered by the Company.  In addition, the ...
Breaking Medicine Technology:Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3
Cached News: